杏林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4569/E00985 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2011/08/12 | 日証協 | 170,308株 | +1.85% | 122,100株 | +48.9% | 239,699株 | +96.44% | 151,299株 | +159% |
2011/08/05 | 日証協 | 167,208株 | -1.76% | 82,000株 | -18.81% | 122,024株 | -44.79% | 58,416株 | +77.02% |
2011/07/29 | 日証協 | 170,208株 | -10.51% | 101,000株 | +90.57% | 221,033株 | -8.3% | 33,000株 | -25.7% |
2011/07/22 | 日証協 | 190,208株 | -2.46% | 53,000株 | -64.14% | 241,033株 | -0.74% | 44,416株 | -54.03% |
2011/07/15 | 日証協 | 195,000株 | -0.62% | 147,792株 | -17.43% | 242,825株 | +5.1% | 96,624株 | +12.12% |
2011/07/08 | 日証協 | 196,208株 | -2.11% | 179,000株 | +108.14% | 231,033株 | -2.63% | 86,180株 | +41.83% |
2011/07/01 | 日証協 | 200,444株 | -2.91% | 86,000株 | -28.93% | 237,269株 | +98.94% | 60,764株 | +106.57% |
2011/06/24 | 日証協 | 206,444株 | -6.35% | 121,000株 | +39.08% | 119,269株 | -49.31% | 29,416株 | -38.72% |
2011/06/17 | 日証協 | 220,444株 | +2.74% | 87,000株 | -4.4% | 235,269株 | -12.99% | 48,000株 | -66.99% |
2011/06/10 | 日証協 | 214,572株 | -1.77% | 91,000株 | +311% | 270,397株 | +13.49% | 145,416株 | +227.99% |
2011/06/03 | 日証協 | 218,431株 | -0.82% | 22,141株 | -77.11% | 238,256株 | -6.59% | 44,336株 | -34.44% |
2011/05/27 | 日証協 | 220,236株 | +1.73% | 96,727株 | +104.18% | 255,061株 | +3.57% | 67,624株 | -28.06% |
2011/05/20 | 日証協 | 216,496株 | +22.7% | 47,373株 | -34.13% | 246,269株 | +29.43% | 94,000株 | +161.11% |
2011/05/13 | 日証協 | 176,444株 | +25.84% | 71,915株 | +43.83% | 190,269株 | +7.94% | 36,000株 | +227.27% |
2011/05/06 | 日証協 | 140,208株 | -2.09% | 50,000株 | +108.33% | 176,270株 | -5.37% | 11,000株 | -75% |
2011/04/28 | 日証協 | 143,208株 | +7.51% | 24,000株 | -51.02% | 186,270株 | +6.89% | 44,000株 | -2.22% |
2011/04/22 | 日証協 | 133,208株 | -1.48% | 49,000株 | -32.04% | 174,270株 | -12.1% | 45,000株 | -74.89% |
2011/04/15 | 日証協 | 135,208株 | -8.77% | 72,100株 | -47.37% | 198,270株 | -5.26% | 179,200株 | +105.98% |
2011/04/08 | 日証協 | 148,208株 | -7.49% | 137,000株 | -20.81% | 209,270株 | -7.1% | 86,999株 | +50.43% |
※株式分割は考慮していませんのでご注意ください。
Page Top